Your browser doesn't support javascript.
loading
Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity.
Chan, Cerise Yuen-Ki; Yuen, Vincent Wai-Hin; Chiu, David Kung-Chun; Goh, Chi-Ching; Thu, Kelsie L; Cescon, David W; Soria-Bretones, Isabel; Law, Cheuk-Ting; Cheu, Jacinth Wing-Sum; Lee, Derek; Tse, Aki Pui-Wah; Tan, Kel Vin; Zhang, Misty Shuo; Wong, Bowie Po-Yee; Wong, Chun-Ming; Khong, Pek-Lan; Ng, Irene Oi-Lin; Bray, Mark R; Mak, Tak Wah; Yau, Thomas Chung-Cheung; Wong, Carmen Chak-Lui.
Afiliação
  • Chan CY; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
  • Yuen VW; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China.
  • Chiu DK; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
  • Goh CC; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China.
  • Thu KL; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
  • Cescon DW; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
  • Soria-Bretones I; The Campbell Family Institute for Breast Cancer Research , Princess Margaret Cancer Centre , Toronto , Ontario , Canada.
  • Law CT; The Campbell Family Institute for Breast Cancer Research , Princess Margaret Cancer Centre , Toronto , Ontario , Canada.
  • Cheu JW; The Campbell Family Institute for Breast Cancer Research , Princess Margaret Cancer Centre , Toronto , Ontario , Canada.
  • Lee D; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
  • Tse AP; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
  • Tan KV; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China.
  • Zhang MS; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
  • Wong BP; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China.
  • Wong CM; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
  • Khong PL; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China.
  • Ng IO; Department of Diagnostic Radiology , The University of Hong Kong , Hong Kong SAR , China.
  • Bray MR; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
  • Mak TW; Centre for Oncology and Immunology , Hong Kong Science Park , Hong Kong SAR , China.
  • Yau TC; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
  • Wong CC; Department of Pathology , The University of Hong Kong , Hong Kong SAR , China.
Hepatology ; 77(3): 729-744, 2023 03 01.
Article em En | MEDLINE | ID: mdl-35302667
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article